BMRN vs ROIV
BioMarin Pharmaceutical Inc. · Roivant Sciences Ltd.
Relative return (rebased to 100)
Key stats
| Metric | BMRN | ROIV |
|---|---|---|
| Price | $57.54 | $35.78 |
| Market Cap | $11.14B | $25.84B |
| P/E | 31.92 | — |
| P/B | 1.76 | 6.11 |
| P/S | 3.46 | 3128.90 |
| ROE | 5.5% | -7.1% |
| Net Margin | 10.8% | -3629.2% |
| Gross Margin | — | — |
| Revenue Growth | 12.9% | -71.6% |
| Dividend Yield | — | — |
| EPS | $1.80 | -$0.42 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.